US · USD
NAMSW
NewAmsterdam Pharma Company N.V. Warrant
- Day's range
- $10.41 – $11.00
- Day's volume
- $16.5K
- 52-week range
- $11.00 – $29.99
Follow NAMSW in the Fuolio
See how NAMSW weighs in your net worth, what it has paid you and how far it is from your target allocation.
Create a free accountNAMSW in numbers
- Market cap
- $1.3B
- P/E
- -5.08
- P/B
- 2.08
- Dividend yield (12m)
- 0.00%
NAMSW price history
NAMSW risk and return
Monthly closes adjusted for splits and distributions.
| Metric | 12 months | 36 months | 60 months |
|---|---|---|---|
| Return | -59.23% | +528.57% | +1,471.43% |
| Volatility (annualized) | 64.73% | 136.96% | 387.47% |
| Largest drawdown | -62.96% | -62.96% | -89.61% |
| Positive months | 4/12 | 21/36 | 30/60 |
How much did investing in NAMSW return?
$1,000.00 invested on 10/01/2021 would be worth $15,714.29 today.
- Value today in NAMSW
- $15,714.29
- Return over the period
- +1,471.43%
- Return per year
- +73.50%
- In the S&P 500
- $1,697.78
With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.
NAMSW fundamentals
Valuation
- P/E-5.08
- P/B2.08
- EV/EBITDA-5.39
- EV/EBIT-5.38
- EV/Revenue184.65
- P/EBIT-5.38
- P/S184.65
- P/OCF-9.17
- P/FCF—
- Earnings yield-18.59%
- PEG ratio—
- Earnings per share-$2.16
- Book value per share$5.28
Debt
- Net debt—
- Net debt/EBITDA—
- Net debt/Equity—
- Debt/Equity—
- Current ratio9.03
- Quick ratio—
- Cash ratio8.69
Efficiency
- Gross margin—
- EBITDA margin-3,427.50%
- Operating margin-3,432.20%
- Net margin-3,632.71%
- Asset turnover0.01
Profitability
- ROE-40.97%
- ROA-36.72%
- ROIC-38.71%
- Payout—
Growth
- Revenue CAGR (5 years)-34.63%
- Earnings CAGR (5 years)—
- Revenue growth (year)—
- Earnings growth (year)—
- Revenue growth (quarter)—
- Earnings growth (quarter)—
NAMSW's indicators by year
Multiples at each year's closing price; margins and returns from that year's statements.
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| P/E | -13.03 | -6.47 | -1.58 | — | — |
| P/B | 3.87 | 2.07 | 0.97 | — | — |
| Earnings per share | -$1.77 | -$2.20 | -$1.98 | — | — |
| Book value per share | $5.94 | $6.90 | $3.23 | — | — |
| ROE | -29.70% | -31.95% | -61.37% | -5.26% | 36.71% |
| ROIC | -33.02% | -23.27% | -63.44% | -0.83% | — |
| EBITDA margin | -1,001.92% | -386.66% | -1,298.21% | -3.45% | — |
| Net margin | -902.10% | -531.13% | -1,256.21% | -22.04% | — |
NAMSW's financial statements
| Line | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Net revenue | $22.5M | $45.6M | $14.1M | $102.7M | — |
| Cost of revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| EBITDA | -$225.5M | -$176.2M | -$182.9M | -$3.5M | -$35M |
| EBIT | -$225.7M | -$176.3M | -$183M | -$3.6M | -$35M |
| Financial result | — | — | — | — | — |
| Income before tax | -$203.8M | -$241.6M | -$176.9M | -$22.6M | -$41.8M |
| Income tax | — | $1K | -$27K | — | — |
| Net income | -$203M | -$242M | -$177M | -$22.6M | -$41.8M |
Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.
Does NAMSW pay dividends?
NAMSW has no distributions on record.
About Newamsterdam Pharma Company
- Sector
- Manufacturing
Questions about NAMSW
How much is NAMSW today?
NAMSW is at $11.00 (-8.33% on the day), last traded on 10/06/2026.
What are the P/E and P/B of NAMSW?
NAMSW trades at a P/E of -5.08 and a P/B of 2.08.
How much did NAMSW return in 12 months?
NAMSW returned -59.23% in 12 months, with annualized volatility of 64.73% and a largest drawdown of -62.96%.